Canal Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$5.3M Sell
29,806
-1,113
-4% -$198K 0.86% 34
2024
Q3
$6.11M Buy
30,919
+317
+1% +$62.6K 0.98% 34
2024
Q2
$5.25M Buy
30,602
+958
+3% +$164K 0.9% 38
2024
Q1
$5.4M Buy
29,644
+2,886
+11% +$526K 0.91% 39
2023
Q4
$4.15M Buy
26,758
+2,198
+9% +$341K 0.77% 39
2023
Q3
$3.66M Buy
24,560
+704
+3% +$105K 0.75% 41
2023
Q2
$3.21M Buy
23,856
+1,364
+6% +$184K 0.65% 44
2023
Q1
$3.58M Buy
22,492
+15,041
+202% +$2.4M 0.79% 37
2022
Q4
$1.2M Buy
7,451
+180
+2% +$29.1K 0.29% 72
2022
Q3
$976K Buy
7,271
+24
+0.3% +$3.22K 0.28% 69
2022
Q2
$1.11M Buy
7,247
+63
+0.9% +$9.65K 0.33% 65
2022
Q1
$1.17M Sell
7,184
-44
-0.6% -$7.14K 0.31% 65
2021
Q4
$979K Buy
7,228
+56
+0.8% +$7.59K 0.24% 72
2021
Q3
$774K Sell
7,172
-18
-0.3% -$1.94K 0.22% 75
2021
Q2
$810K Buy
7,190
+422
+6% +$47.5K 0.23% 76
2021
Q1
$732K Sell
6,768
-21
-0.3% -$2.27K 0.25% 78
2020
Q4
$727K Buy
6,789
+325
+5% +$34.8K 0.27% 76
2020
Q3
$566K Sell
6,464
-87
-1% -$7.62K 0.25% 81
2020
Q2
$643K Buy
6,551
+196
+3% +$19.2K 0.31% 72
2020
Q1
$484K Buy
6,355
+2,183
+52% +$166K 0.27% 75
2019
Q4
$369K Sell
4,172
-563
-12% -$49.8K 0.19% 87
2019
Q3
$359K Sell
4,735
-208
-4% -$15.8K 0.22% 89
2019
Q2
$359K Sell
4,943
-16,591
-77% -$1.2M 0.22% 85
2019
Q1
$1.74M Buy
21,534
+693
+3% +$55.8K 1.1% 31
2018
Q4
$1.92M Buy
20,841
+1,003
+5% +$92.5K 1.3% 22
2018
Q3
$1.88M Buy
19,838
+15,995
+416% +$1.51M 1.07% 32
2018
Q2
$356K Sell
3,843
-40
-1% -$3.71K 0.2% 104
2018
Q1
$368K Buy
3,883
+23
+0.6% +$2.18K 0.21% 100
2017
Q4
$373K Buy
3,860
+98
+3% +$9.47K 0.21% 94
2017
Q3
$334K Buy
3,762
+8
+0.2% +$710 0.2% 93
2017
Q2
$272K Buy
3,754
+9
+0.2% +$652 0.17% 105
2017
Q1
$244K Sell
3,745
-141
-4% -$9.19K 0.17% 105
2016
Q4
$243K Buy
3,886
+33
+0.9% +$2.06K 0.2% 74
2016
Q3
$243K Buy
3,853
+30
+0.8% +$1.89K 0.23% 66
2016
Q2
$237K Sell
3,823
-2,404
-39% -$149K 0.25% 63
2016
Q1
$356K Buy
+6,227
New +$356K 0.36% 53